Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan

被引：0
|
作者：
Mai, Nicholas
Klar, Miriam
Ferraro, Emanuela
Bromberg, Maria
Chen, Yuan
Razavi, Pedram
Modi, Shanu
Chandarlapaty, Sarat
Walsh, Elaine M.
Drago, Joshua Z.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1085
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sacituzumab govitecan vs. chemotherapy for metastatic breast cancer: a meta-analysis on safety outcomes
    Rizzo, Alessandro
    Rinaldi, Lucia
    Massafra, Raffaella
    Cusmai, Antonio
    Guven, Deniz Can
    Forgia, Daniele La
    Latorre, Agnese
    Giotta, Francesco
    FUTURE ONCOLOGY, 2024, 20 (20) : 1427 - 1434
  • [32] Metastatic triple-negative Breast Cancer (mTNBC) First-in-class Therapy with Sacituzumab Govitecan
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 64 - 65
  • [33] Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
    Reinisch, Mattea
    Bruzas, Simona
    Spoenlein, Jennifer
    Shenoy, Satyendra
    Traut, Alexander
    Harrach, Hakima
    Chiari, Ouafaa
    Cremer, Efsthatia
    Ataseven, Beyhan
    Gubelt, Lars
    Kuemmel, Sherko
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [34] Metastatic triple-negative breast cancer (mTNBC) first-in-class therapy with sacituzumab govitecan
    Schoellmann, Claudia
    BREAST CARE, 2022, 17 (01)
  • [35] Administration of trastuzumab deruxtecan in metastatic breast cancer patients with severe hepatic impairment
    Sun, Laura
    Moore, Gaybrielle
    Labatut, Annalise
    Meisel, Jane
    Kalinsky, Kevin
    Byers, Kristina
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 16
  • [36] Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer
    Tarantino, Paolo
    Lee, Do
    Foldi, Julia
    Soulos, Pamela R.
    Gross, Cary Philip
    Grinda, Thomas
    Winer, Eric P.
    Lin, Nancy U.
    Krop, Ian E.
    Tolaney, Sara M.
    Lustberg, Maryam B.
    Sammons, Sarah L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] CNS efficacy of trastuzumab deruxtecan in metastatic breast cancer: A single-institution, real-world analysis.
    Zhang, Xiaojie
    Yeung, Kay T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
    Fabi, Alessandra
    Rossi, Alessandro
    Caputo, Roberta
    Pisegna, Simona
    Scagnoli, Simone
    Pantano, Francesco
    D'Auria, Giuliana
    Fedele, Palma
    Fabbri, Agnese
    Vernieri, Claudio
    Palleschi, Michela
    Carbognin, Luisa
    Ferretti, Gianluigi
    Di Monte, Elena
    Paris, Ida
    Pavese, Francesco
    Garrone, Ornella
    Franco, Antonio
    De Laurentiis, Michelino
    Franceschini, Gianluca
    Scambia, Giovanni
    Giannarelli, Diana
    Masetti, Riccardo
    Botticelli, Andrea
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [39] FEASIBILITY ASSESSMENT OF AN INDIRECT TREATMENT COMPARISON (ITC) OF SACITUZUMAB GOVITECAN (SG) VS TRASTUZUMAB DERUXTECAN (T-DXD) IN HR+/HER2-METASTATIC BREAST CANCER (MBC)
    Shah, A.
    Thaliffdeen, R.
    Proudman, D.
    Verret, W.
    Sjekloca, N.
    Campone, M.
    VALUE IN HEALTH, 2023, 26 (12) : S545 - S545
  • [40] Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
    Caputo, Roberta
    Buono, Giuseppe
    Piezzo, Michela
    Martinelli, Claudia
    Cianniello, Daniela
    Rizzo, Alessandro
    Pantano, Francesco
    Staropoli, Nicoletta
    Cangiano, Rodolfo
    Turano, Salvatore
    Paris, Ida
    Nuzzo, Francesco
    Fabi, Alessandra
    De Laurentiis, Michelino
    FRONTIERS IN ONCOLOGY, 2024, 14
12345